- £218.75bn
- £236.77bn
- $54.07bn
- 78
- 14
- 98
- 73
REG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Enhertu granted Priority Review for breast cancer
AnnouncementREG - AstraZeneca PLC - AstraZeneca and Neurimmune sign deal for NI006
AnnouncementREG - AstraZeneca PLC - Transfer of rights to Eklira, Duaklir completed
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca and Ionis close eplontersen deal
AnnouncementREG - AstraZeneca PLC - Ultomiris accepted for FDA Priority Review for gMG
AnnouncementREG - AstraZeneca PLC - Tezspire approved in the US for severe asthma
AnnouncementREG - AstraZeneca PLC - Saphnelo recommended for EU approval for SLE
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Evusheld US FDA EUA
AnnouncementREG - AstraZeneca PLC - AstraZeneca, Ionis to collaborate on eplontersen
AnnouncementREG - Schroder UK PublicPT - BenevolentAI Transaction
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Lynparza granted FDA Priority Review for OlympiA
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AZN: Year to date and Q3 2021 results
Announcement